10-K Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 FY 2012

Filing Information

Form Type	10-K
Accession Number	`0001513160-13-000055`
Period End Date	20121231
Filing Date	20130923
Fiscal Year	2012
Fiscal Period	FY
XBRL Instance	gnpb-20121231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 47 Cash Flow Statement 109 Stockholders Equity 46

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$2.70K	USD	Point-in-time
Cash and cash equivalents	`Cash`	$510.22K	USD	Point-in-time
Cash and cash equivalents	`Cash`	-	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$8.91K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$9.39K	USD	Point-in-time
Deposits	`PrepaidExpenseAndOtherAssetsCurrent`	$5.00K	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.27K	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock Par Value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.47K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$7.28K	USD	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Common Stock Shares Authorized	`CommonStockSharesAuthorized`	1.80B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$524.08K	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $8,915 and $2,704	`PropertyPlantAndEquipmentNet`	$28.35K	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	77.99M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $8,915 and $2,704	`PropertyPlantAndEquipmentNet`	$22.14K	USD	Point-in-time
Common Stock Shares Issued	`CommonStockSharesIssued`	81.88M	shares	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	77.99M	shares	Point-in-time
Common Stock Shares Outstanding	`CommonStockSharesOutstanding`	81.88M	shares	Point-in-time
Rent Deposit	`DepositsAssetsNoncurrent`	-	USD	Point-in-time
Rent Deposit	`DepositsAssetsNoncurrent`	$16.00K	USD	Point-in-time
Total assets	`Assets`	$29.41K	USD	Point-in-time
Total assets	`Assets`	$568.43K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$190.05K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10M	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$1.74M	USD	Point-in-time
Accrued expenses	`InterestPayableCurrent`	$67.90K	USD	Point-in-time
7% convertible promissory notes	`ConvertibleNotesPayableCurrent`	$5.00M	USD	Point-in-time
7% convertible promissory notes	`ConvertibleNotesPayableCurrent`	$5.00M	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	-	USD	Point-in-time
12% secured promissory notes	`SecuredPromissoryNotes`	$1.23M	USD	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	-	USD	Point-in-time
September 2012 secured promissory note	`SecuredDebtCurrent`	$250.00K	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	$2.03M	USD	Point-in-time
Accrued interest and penalty	`AccruedInterestAndPenalty`	$153.61K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	-	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$7.94M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$11.35M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$13.35M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 1,800,000,000 shares authorized, 81,880,595 and 77,993,591 shares issued and outstanding, respectively	`CommonStockValue`	$3.25K	USD	Point-in-time
Common stock, $0.000041666 par value; 1,800,000,000 shares authorized, 81,880,595 and 77,993,591 shares issued and outstanding, respectively	`CommonStockValue`	$3.41K	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	$245.15K	USD	Point-in-time
Common shares to be issued, 303,125 shares	`CommonSharesToBeIssuedWith12SecuredPromissoryNotes`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$14.59M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$19.12M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-27.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-30.68M	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$2.28K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$61.00K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$638.09K	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	-	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Total Stockholders' Equity (Deficiency)	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$29.41K	USD	Point-in-time
Total Liabilities and Stockholders' Deficiency	`LiabilitiesAndStockholdersEquity`	$568.43K	USD	Point-in-time

Income Statement 47 line items

Line Item	Tag	Value	Unit	Period
Revenues	`SalesRevenueGoodsNet`	-	USD	Annual
Revenues	`SalesRevenueGoodsNet`	-	USD	Annual
Revenues	`SalesRevenueGoodsNet`	-	USD	21 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$4.20M	USD	Annual
Share-Based Compensation	`ShareBasedCompensation`	$16.36M	USD	21 Qtrs
Share-Based Compensation	`ShareBasedCompensation`	$14.61M	USD	Annual
Operating expenses (including $4,203,254, $14,608,040 and $16,361,663 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$19.30M	USD	Annual
Operating expenses (including $4,203,254, $14,608,040 and $16,361,663 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$26.50M	USD	21 Qtrs
Operating expenses (including $4,203,254, $14,608,040 and $16,361,663 of non-cash share-based compensation costs)	`OperatingCostsAndExpenses`	$6.48M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.76M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$3.58M	USD	21 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.66M	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	21 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Total costs and expenses	`OperatingExpenses`	$30.24M	USD	21 Qtrs
Total costs and expenses	`OperatingExpenses`	$8.13M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$21.22M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-21.22M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-8.13M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-30.24M	USD	21 Qtrs
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$1.60M	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$8.64M	USD	Annual
Change in fair value of derivative liability	`IncreaseDecreaseInFairValueOfUnhedgedDerivativeInstruments`	$10.00M	USD	21 Qtrs
Interest expense	`InterestExpense`	$1.92M	USD	Annual
Interest expense	`InterestExpense`	$151.51K	USD	Annual
Interest expense	`InterestExpense`	$2.07M	USD	21 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$497.89K	USD	Annual
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.50M	USD	21 Qtrs
Amortization of discount on convertible notes	`AmortizationOfDebtDiscountPremium`	$5.00M	USD	Annual
Financing costs	`PrivatePlacementCosts`	$1.39M	USD	Annual
Financing costs	`PrivatePlacementCosts`	$2.87M	USD	21 Qtrs
Financing costs	`PrivatePlacementCosts`	$920.31K	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-443.08K	USD	21 Qtrs
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-4.48M	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$4.82M	USD	Annual
Net Loss	`NetIncomeLoss`	$-3.31M	USD	Annual
Net Loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net Loss	`NetIncomeLoss`	$-58.72K	USD	Annual
Net Loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net Loss	`NetIncomeLoss`	$-30.68M	USD	21 Qtrs
Net Loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	-	USD	21 Qtrs
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	Annual
Net Loss Per Share, Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	Annual
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	75.92M	shares	Annual
Weighted-Average Common Shares Outstanding, Basic and Diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	79.85M	shares	Annual

Cash Flow Statement 109 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.31M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net loss	`NetIncomeLoss`	$-58.72K	USD	Annual
Net loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-30.68M	USD	21 Qtrs
Net loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$6.21K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$70.29K	USD	21 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$2.70K	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	21 Qtrs
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	$160.04K	USD	Annual
Impairment of intangible asset	`ImpairmentOfIntangibleAssetsExcludingGoodwill`	-	USD	Annual
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$1.79M	USD	Annual
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$4.44M	USD	21 Qtrs
Fair value of vested stock options and warrants	`StockOptionPlanExpense`	$2.53M	USD	Annual
Fair value of derivative liability recorded upon issuance of warrants	`FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants`	$2.56M	USD	21 Qtrs
Fair value of derivative liability recorded upon issuance of warrants	`FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants`	-	USD	Annual
Fair value of derivative liability recorded upon issuance of warrants	`FairValueOfDerivativeLiabilityRecordedUponIssuanceOfWarrants`	$2.56M	USD	Annual
Amortization of discount on notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$5.50M	USD	21 Qtrs
Amortization of discount on notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$5.00M	USD	Annual
Amortization of discount on notes	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$497.89K	USD	Annual
Private placement costs	`PrivatePlacementCosts1`	$920.31K	USD	Annual
Private placement costs	`PrivatePlacementCosts1`	$515.27K	USD	Annual
Private placement costs	`PrivatePlacementCosts1`	$2.00M	USD	21 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-8.64M	USD	Annual
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-10.00M	USD	21 Qtrs
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-1.60M	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	Annual
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	$8.01M	USD	21 Qtrs
Common stock issued to officer for services	`CommonStockIssuedToOfficerForServices`	-	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$800.00K	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.30M	USD	21 Qtrs
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$498.45K	USD	Annual
Common stock issued with note payable reflected as financing cost	`CommonStockIssuedWithNotePayableReflectedAsFinancingCost`	$875.00K	USD	Annual
Common stock issued with note payable reflected as financing cost	`CommonStockIssuedWithNotePayableReflectedAsFinancingCost`	$875.00K	USD	21 Qtrs
Common stock issued with note payable reflected as financing cost	`CommonStockIssuedWithNotePayableReflectedAsFinancingCost`	-	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	-	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	Annual
Fair value of common stock transferred to officer and director	`FairValueOfCommonStockTransferredToOfficerAndDirector`	$1.74M	USD	21 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	Annual
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	$50.00K	USD	21 Qtrs
Write off of advances to related party	`WriteOffOfAdvancesToRelatedParty`	-	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$22.59K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-21.42K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-7.28K	USD	21 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.10M	USD	21 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$908.22K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$159.76K	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.67M	USD	Annual
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.89M	USD	21 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$70.00K	USD	Annual
Accrued interest and penalty	`AccruedInterestAndPenalty1`	$1.88M	USD	Annual
Accrued interest and penalty	`AccruedInterestAndPenalty1`	$151.51K	USD	Annual
Accrued interest and penalty	`AccruedInterestAndPenalty1`	$1.88M	USD	21 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.19M	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.12M	USD	21 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.24M	USD	Annual
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$35.05K	USD	21 Qtrs
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$31.05K	USD	Annual
Property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	Annual
Advances to related party	`PaymentsToFundLongtermLoansToRelatedParties`	$50.00K	USD	21 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-85.05K	USD	21 Qtrs
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	$-81.05K	USD	Annual
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	Annual
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$4.62M	USD	Annual
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$4.62M	USD	21 Qtrs
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	$1.48M	USD	21 Qtrs
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	-	USD	Annual
Proceeds from the issuance of secured promissory notes	`ProceedsFromIssuanceOfSecuredPromissoryNotesNet`	$1.48M	USD	Annual
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$3.09M	USD	21 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.00K	USD	Annual
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$873.00K	USD	Annual
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	$18.14K	USD	21 Qtrs
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	Annual
Due to director	`IncreaseDecreaseInDueToOfficersAndStockholders`	-	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$5.49M	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$9.21M	USD	21 Qtrs
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$1.73M	USD	Annual
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	-	USD	21 Qtrs
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-782.25K	USD	Annual
Net Increase (Decrease) In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-510.22K	USD	Annual
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$510.22K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.29M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	21 Qtrs
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	-	USD	Annual
Derivative liability recorded upon issuance of convertible notes and warrants	`DerivativeLiabilityRecordedUponIssuanceOfConvertibleNotesAndAttachedWarrants`	$5.54M	USD	Annual
Derivative liability recorded as financing cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$697.35K	USD	Annual
Derivative liability recorded as financing cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$642.30K	USD	Annual
Derivative liability recorded as financing cost	`DerivativeLiabilityRecordedAsPrivatePlacementCost`	$1.34M	USD	21 Qtrs
Common stock issued for intellectual property	`StockIssued1`	-	USD	Annual
Common stock issued for intellectual property	`StockIssued1`	$217.41K	USD	21 Qtrs
Common stock issued for intellectual property	`StockIssued1`	-	USD	Annual
Proceeds from convertible notes held in escrow	`ProceedsFromConvertibleNotesHeldInEscrow`	$497.89K	USD	Annual
Proceeds from convertible notes held in escrow	`ProceedsFromConvertibleNotesHeldInEscrow`	$497.89K	USD	21 Qtrs
Proceeds from convertible notes held in escrow	`ProceedsFromConvertibleNotesHeldInEscrow`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director, treated as contribution of capital	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	21 Qtrs

Stockholders Equity 46 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance Amount	`StockholdersEquity`	$2.28K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$61.00K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	-	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Beginning Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Initial capitalization, sale of common stock to directors, September 17, 2007, amount	`StockIssuedDuringPeriodValueNewIssues`	$8.00K	USD	1 Quarter
Private placement, closed December 31, 2007, amount	`StockIssuedDuringPeriodValueOther`	$53.00K	USD	1 Quarter
Common stock sold in private placement at $0.03125 per share, March 2010, amount	`CommonStockSoldInPrivatePlacementAt0.03125PerShareMarch2010Amount`	$365.00K	USD	Annual
Common stock issued for intellectual property, amount	`StockIssuedDuringPeriodValuePurchaseOfAssets`	$217.41K	USD	Annual
Common stock sold in private placement at $0.75 per share, September 2010, amount	`CommonStockSoldInPrivatePlacementAt0.75PerShareSeptember2010Amount`	$700.00K	USD	Annual
Common stock sold in private placement at $1.00 per share, October 2010, amount	`CommonStockSoldInPrivatePlacementAt1.00PerShareOctober2010Amount`	$250.00K	USD	Annual
Common stock sold in private placement at $1.00 per share, December 2010, amount	`CommonStockSoldInPrivatePlacementAt1.00PerShareDecember2010Amount`	$595.00K	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	-	USD	Annual
Forgiveness of debt by director	`DebtInstrumentDecreaseForgiveness`	$18.14K	USD	21 Qtrs
Common Stock sold in Private Placement at $1.00 per share, January 2011, Amount	`CommonStockSoldInPrivatePlacementAt100PerShareJanuary2011Amount`	$45.00K	USD	Annual
Common Stock sold in Private Placement at $1.00 per share, April to June 2011, Amount	`CommonStockSoldInPrivatePlacementAt1PerShareAprilToJune2011Amount`	$185.70K	USD	Annual
Common Stock sold in Private Placement at $1.00 per share, net of derivative liability, February 2012, Amount	`CommonStockSoldInPrivatePlacementAt1.00PerShareFebruary2012Amount`	$67.92K	USD	Annual
Fair value of common stock issued to consultatnt for services, Amount	`FairValueOfCommonStockIssuedToConsultatntForServicesAmount`	$498.45K	USD	Annual
Common stock issued to consultants for services, Amount	`CommonStockIssuedToConsultantsForServicesAmount`	$800.00K	USD	Annual
Cancellation of shares, Amount	`CancellationOfSharesAmount`	-	USD	Annual
Fair value of common stock issued to officer for services, Amount	`FairValueOfCommonStockIssuedToOfficerForServicesAmount`	$8.01M	USD	Annual
Fair value of common stock issued with notes payable, Amount	`FairValueOfCommonStockIssuedWithNotesPayableAmount`	$497.89K	USD	Annual
Fair value of common stock issued with notes payable recorded as financing cost, Amount	`FinancingCost`	$875.00K	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$1.79M	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$114.02K	USD	Annual
Fair value of vested stock options and warrants	`FairValueOfVestedStockOptionsAndWarrants`	$2.53M	USD	Annual
Fair value of common stock transferred to officer	`FairValueOfCommonStockTransferredToOfficer`	$702.04K	USD	Annual
Fair value of common stock transferred from CEO to a director	`FairValueOfCommonStockTransferredFromCeoToDirector`	$1.04M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.31M	USD	Annual
Net loss	`NetIncomeLoss`	$-1.61M	USD	Annual
Net loss	`NetIncomeLoss`	$-58.72K	USD	Annual
Net loss	`NetIncomeLoss`	$-25.69M	USD	Annual
Net loss	`NetIncomeLoss`	$-30.68M	USD	21 Qtrs
Net loss	`NetIncomeLoss`	$-15.77K	USD	Annual
Ending Balance Amount	`StockholdersEquity`	$2.28K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$61.00K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-13.49K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$638.09K	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	-	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-12.78M	USD	Point-in-time
Ending Balance Amount	`StockholdersEquity`	$-11.32M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.